Pfizer Slashes Research, Staff after Wyeth Deal

Nov. 9, 2009
R&D will be conducted at five main sites and nine specialized units around the world, compared with 20 R&D sites.

Pfizer announced on Nov. 9 cuts in its research activities and staff after acquiring pharmaceutical rival Wyeth. Research and development activities will now be conducted at five main sites and nine specialized units around the world, compared with 20 R&D sites on completion of the Wyeth deal in mid-October, the company said.

The company will move a number of functions from three U.S. centers to other locations and will discontinue R&D operations in six local centers as well. R&D operations at Gosport, Slough/Taplow in Britain will also be discontinued. "As a result of these changes, Pfizer will reduce its global R&D square footage by 35%," the statement said.

Pfizer will now have five main research sites that will serve as central hubs for research activities in BioTherapeutics, PharmaTherapeutics and Vaccines, the company said. These sites are in Cambridge, Mass.; Groton, Conn.; Pearl River, N.Y.; La Jolla, Calif.; and Sandwich, Britain.

These research-oriented laboratories will be supplemented by specialized research capabilities, such as monoclonal antibody discovery in San Francisco, regenerative medicine work in Cambridge, Britain, and research and development activities in Shanghai, China, the statement said.

"While these changes are expected to bolster productivity and reduce costs, they will result in staff reductions," the company said. No specific numbers were given in terms of staff cuts.

Pfizer's acquisition of Wyeth in a $68 billion deal boosted its position as the world's biggest drugmaker as it prepares for the expiration of patents on its blockbuster drugs and as some of its key drugs face competition from generic manufacturers.

Copyright Agence France-Presse, 2009

Popular Sponsored Recommendations

3D Printing a More Efficient Factory Floor

Nov. 16, 2023
Today’s additive manufacturing platforms make it simple to print a wide range of high-performing industrial parts as soon as possible and right where you need them — unlocking...

Food and Beverage 2024 Trends and Outlook for North America

Oct. 29, 2023
Ready to hear what 200 of your peers said are the top challenges and opportunities in 2024? Don’t fall behind. Uncover actionable insights to better prepare for 2024 in this whitepaper...

How Manufacturers Can Optimize Operations with Weather Intelligence

Nov. 2, 2023
The bad news? Severe weather has emerged as one of the biggest threats to continuity and safety in manufacturing. The good news? The intelligence solutions that build weather ...

How to Build Zero-Cost On-Site Solar and Storage Projects

Nov. 25, 2023
The Inflation Reduction Act offers tax credits, incentives, and financing that enable no-cost projects. In Enel’s eBook, discover the critical role that incentives play in your...

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!